Dolby Laboratories, Inc.
DLB · NYSE
9/26/2025 | 9/30/2024 | 9/27/2024 | 9/30/2023 | |
|---|---|---|---|---|
| Revenue | $1 | – | $1 | $1 |
| % Growth | – | – | -2% | – |
| Cost of Goods Sold | $0 | – | $0 | $0 |
| Gross Profit | $1 | – | $1 | $1 |
| % Margin | 88.1% | – | 89% | 88.3% |
| R&D Expenses | $0 | – | $0 | $0 |
| G&A Expenses | $0 | – | $0 | $0 |
| SG&A Expenses | $1 | – | $1 | $1 |
| Sales & Mktg Exp. | $0 | – | $0 | $0 |
| Other Operating Expenses | $0 | – | $0 | $0 |
| Operating Expenses | $1 | – | $1 | $1 |
| Operating Income | $0 | – | $0 | $0 |
| % Margin | 19.6% | – | 20.8% | 20.2% |
| Other Income/Exp. Net | $0 | – | $0 | -$0 |
| Pre-Tax Income | $0 | – | $0 | $0 |
| Tax Expense | $0 | – | $0 | $0 |
| Net Income | $0 | – | $0 | $0 |
| % Margin | 18.9% | – | 20.6% | 15.4% |
| EPS | 2.66 | – | 2.74 | 2 |
| % Growth | – | – | 37% | – |
| EPS Diluted | 2.62 | – | 2.69 | 1.96 |
| Weighted Avg Shares Out | 0 | – | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | – | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | – | $0 | $0 |
| Interest Expense | $0 | – | $0 | $0 |
| Depreciation & Amortization | $0 | – | $0 | $0 |
| EBITDA | $0 | – | $0 | $0 |
| % Margin | 28.1% | – | 31.4% | 26.6% |